LeMaitre Vascular Income Taxes 2010-2024 | LMAT
LeMaitre Vascular Annual Income Taxes (Millions of US $) |
|
---|---|
2024 | $13 |
2023 | $9 |
2022 | $7 |
2021 | $7 |
2020 | $6 |
2019 | $4 |
2018 | $6 |
2017 | $4 |
2016 | $6 |
2015 | $4 |
2014 | $2 |
2013 | $1 |
2012 | $1 |
2011 | $2 |
2010 | $-2 |
2009 | $1 |
LeMaitre Vascular Quarterly Income Taxes (Millions of US $) |
|
---|---|
2024-12-31 | $3 |
2024-09-30 | $3 |
2024-06-30 | $4 |
2024-03-31 | $3 |
2023-12-31 | $3 |
2023-09-30 | $2 |
2023-06-30 | $2 |
2023-03-31 | $2 |
2022-12-31 | $2 |
2022-09-30 | $1 |
2022-06-30 | $2 |
2022-03-31 | $2 |
2021-12-31 | $2 |
2021-09-30 | $2 |
2021-06-30 | $2 |
2021-03-31 | $2 |
2020-12-31 | $2 |
2020-09-30 | $2 |
2020-06-30 | $1 |
2020-03-31 | $1 |
2019-12-31 | $1 |
2019-09-30 | $1 |
2019-06-30 | $1 |
2019-03-31 | $1 |
2018-12-31 | $1 |
2018-09-30 | $0 |
2018-06-30 | $3 |
2018-03-31 | $1 |
2017-12-31 | $2 |
2017-09-30 | $0 |
2017-06-30 | $1 |
2017-03-31 | $1 |
2016-12-31 | $1 |
2016-09-30 | $2 |
2016-06-30 | $1 |
2016-03-31 | $1 |
2015-12-31 | $1 |
2015-09-30 | $1 |
2015-06-30 | $1 |
2015-03-31 | $1 |
2014-12-31 | $1 |
2014-09-30 | $1 |
2014-06-30 | $1 |
2014-03-31 | $0 |
2013-12-31 | $0 |
2013-09-30 | $0 |
2013-06-30 | $0 |
2013-03-31 | $0 |
2012-12-31 | $0 |
2012-09-30 | $0 |
2012-06-30 | $1 |
2012-03-31 | $0 |
2011-12-31 | $0 |
2011-09-30 | $1 |
2011-06-30 | $0 |
2011-03-31 | $0 |
2010-12-31 | $-3 |
2010-09-30 | $1 |
2010-06-30 | $0 |
2010-03-31 | $0 |
2009-12-31 | $0 |
2009-09-30 | $0 |
2009-06-30 | $0 |
2009-03-31 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.841B | $0.220B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $233.138B | 28.03 |
Boston Scientific (BSX) | United States | $152.812B | 38.26 |
Stryker (SYK) | United States | $145.981B | 30.52 |
EssilorLuxottica (ESLOY) | France | $128.807B | 0.00 |
Medtronic (MDT) | Ireland | $107.246B | 15.66 |
Lonza Group Ag (LZAGY) | Switzerland | $49.937B | 0.00 |
Haleon (HLN) | United Kingdom | $47.673B | 27.10 |
ResMed (RMD) | United States | $35.644B | 26.77 |
GE HealthCare Technologies (GEHC) | United States | $32.281B | 15.33 |
Agilent Technologies (A) | United States | $30.991B | 20.47 |
Terumo (TRUMY) | Japan | $28.175B | 0.00 |
Koninklijke Philips (PHG) | Netherlands | $22.624B | 16.26 |
Zimmer Biomet Holdings (ZBH) | United States | $18.817B | 12.09 |
Insulet (PODD) | United States | $18.083B | 70.99 |
Baxter (BAX) | United States | $16.011B | 11.95 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
Demant (WILYY) | Denmark | $7.962B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.751B | 22.82 |
Lantheus Holdings (LNTH) | United States | $5.509B | 14.04 |
Prestige Consumer Healthcare (PBH) | United States | $4.312B | 19.21 |
Perrigo (PRGO) | Ireland | $3.684B | 9.34 |
ICU Medical (ICUI) | United States | $3.516B | 25.93 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.417B | 14.88 |
Envista Holdings (NVST) | United States | $3.012B | 25.03 |
QuidelOrtho (QDEL) | United States | $2.459B | 16.96 |
GN Store Nord (GNNDY) | Denmark | $2.020B | 16.73 |
AtriCure (ATRC) | United States | $1.544B | 0.00 |
Neogen (NEOG) | United States | $1.300B | 16.64 |
Green Thumb Industries (GTBIF) | United States | $1.234B | 27.76 |
Kestra Medical Technologies (KMTS) | United States | $1.162B | 0.00 |
AdaptHealth (AHCO) | United States | $1.130B | 11.47 |
BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
InMode (INMD) | Israel | $0.990B | 9.06 |
Phibro Animal Health (PAHC) | United States | $0.901B | 11.53 |
Evolus (EOLS) | United States | $0.651B | 0.00 |
CeriBell (CBLL) | United States | $0.616B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.592B | 0.00 |
Owens & Minor (OMI) | United States | $0.540B | 4.48 |
Valneva SE (VALN) | France | $0.534B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.405B | 0.00 |
Surmodics (SRDX) | United States | $0.389B | 0.00 |
Omeros (OMER) | United States | $0.368B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.356B | 13.11 |
SNDL (SNDL) | Canada | $0.344B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.318B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.267B | 47.50 |
Verano Holdings (VRNOF) | United States | $0.266B | 0.00 |
Cerus (CERS) | United States | $0.260B | 0.00 |
ZimVie (ZIMV) | United States | $0.256B | 11.63 |
Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
Quanterix (QTRX) | United States | $0.214B | 0.00 |
Biote (BTMD) | United States | $0.205B | 5.75 |
OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
High Tide (HITI) | Canada | $0.193B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.177B | 14.25 |
TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
Brainsway (BWAY) | Israel | $0.167B | 52.18 |
FitLife Brands (FTLF) | United States | $0.149B | 18.33 |
Organigram Global (OGI) | Canada | $0.149B | 0.00 |
Jin Medical (ZJYL) | China | $0.130B | 0.00 |
Exagen (XGN) | United States | $0.111B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
MacroGenics (MGNX) | United States | $0.097B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
Agape ATP (ATPC) | $0.078B | 0.00 | |
Fonar (FONR) | United States | $0.078B | 10.91 |
Veru (VERU) | United States | $0.076B | 0.00 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
Zynex (ZYXI) | United States | $0.064B | 0.00 |
United Health Products (UEEC) | United States | $0.058B | 0.00 |
Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
ImmuCell (ICCC) | United States | $0.046B | 0.00 |
Apyx Medical (APYX) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.041B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.040B | 58.50 |
Safety Shot (SHOT) | United States | $0.037B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.74 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |